{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:30:10Z","timestamp":1791189010141,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":3591,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1111\/ajt.12045","type":"journal-article","created":{"date-parts":[[2013,1,11]],"date-time":"2013-01-11T13:48:56Z","timestamp":1357912136000},"page":"266-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Recent Progress in the Pathophysiology and Treatment of FSGS Recurrence"],"prefix":"10.1016","volume":"13","author":[{"given":"P.","family":"Cravedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.B.","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.12045_bib1","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1056\/NEJMc1202500","article-title":"Resolution of recurrent focal segmental glomerulosclerosis after retransplantation","volume":"366","author":"Gallon","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.12045_bib2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/ndt\/gfq665","article-title":"The incidence of primary glomerulonephritis worldwide: A systematic review of the literature","volume":"26","author":"McGrogan","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ajt.12045_bib3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0272-6386(04)01081-9","article-title":"Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States","volume":"44","author":"Kitiyakara","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"5993","key":"10.1111\/ajt.12045_bib4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"10.1111\/ajt.12045_bib5","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1053\/snep.2003.50025","article-title":"Trends in the epidemiology of focal segmental glomerulosclerosis","volume":"23","author":"Kitiyakara","year":"2003","journal-title":"Semin Nephrol"},{"key":"10.1111\/ajt.12045_bib6","series-title":"USRDS 2012 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States.","year":"2010"},{"key":"10.1111\/ajt.12045_bib7","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1056\/NEJMra1106556","article-title":"Focal segmental glomerulosclerosis","volume":"365","author":"D\u2019Agati","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.12045_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/ndt\/gfp538","article-title":"Recurrence of focal segmental glomerular sclerosis (FSGS) after renal transplantation","volume":"25","author":"Ponticelli","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ajt.12045_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0140-6736(72)91734-5","article-title":"Recurrence of idiopathic nephrotic syndrome after renal transplantation","volume":"2","author":"Hoyer","year":"1972","journal-title":"Lancet"},{"key":"10.1111\/ajt.12045_bib10","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0b013e318250234a","article-title":"Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis","author":"Chang","year":"2012","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12045_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1056\/NEJMoa013036","article-title":"Risk of renal allograft loss from recurrent glomerulonephritis","volume":"347","author":"Briganti","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1111\/ajt.12045_bib12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1399-3046.2009.01261.x","article-title":"Recurrence of focal segmental glomerulosclerosis in renal allograft: an in-depth review","volume":"14","author":"Vinai","year":"2010","journal-title":"Pediatr Transplant"},{"key":"10.1111\/ajt.12045_bib13","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1172\/JCI0212858","article-title":"Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo\/Mna rats","volume":"109","author":"Le Berre","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1111\/ajt.12045_bib14","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/ndt\/gfq597","article-title":"Development of initial idiopathic nephrotic syndrome and post-transplantation recurrence: evidence of the same biological entity","volume":"26","author":"Le Berre","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ajt.12045_bib15","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1111\/j.1523-1755.2005.00664.x","article-title":"Renal macrophage activation and Th2 polarization precedes the development of nephrotic syndrome in Buffalo\/Mna rats","volume":"68","author":"Le Berre","year":"2005","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.12045_bib16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000185890","article-title":"Genetic regulation of the development of glomerular sclerotic lesions in the BUF\/Mna rat","volume":"54","author":"Matsuyama","year":"1990","journal-title":"Nephron"},{"key":"10.1111\/ajt.12045_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00335-007-9078-5","article-title":"Actin -related protein 3 (Arp3) is mutated in proteinuric BUF\/Mna rats","volume":"19","author":"Akiyama","year":"2008","journal-title":"Mamm Genome"},{"key":"10.1111\/ajt.12045_bib18","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s003359900888","article-title":"A genetic locus susceptible to the overt proteinuria in BUF\/Mna rat","volume":"9","author":"Murayama","year":"1998","journal-title":"Mamm Genome"},{"key":"10.1111\/ajt.12045_bib19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1523-1755.2004.00776.x","article-title":"NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence","volume":"66","author":"Weber","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.12045_bib20","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1681\/ASN.2010010029","article-title":"Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation","volume":"22","author":"Jungraithmayr","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.12045_bib21","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.2215\/CJN.03800609","article-title":"Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis","volume":"5","author":"McCarthy","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/ajt.12045_bib22","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis","volume":"17","author":"Wei","year":"2011","journal-title":"Nat Med"},{"key":"10.1111\/ajt.12045_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm1696","article-title":"Modification of kidney barrier function by the urokinase receptor","volume":"14","author":"Wei","year":"2008","journal-title":"Nat Med"},{"key":"10.1111\/ajt.12045_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1155\/2009\/504294","article-title":"suPAR: The molecular crystal ball","volume":"27","author":"Thuno","year":"2009","journal-title":"Dis Markers"},{"key":"10.1111\/ajt.12045_bib25","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ki.2012.32","article-title":"Serum-soluble urokinase receptor concentration in primary FSGS","volume":"81","author":"Maas","year":"2012","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.12045_bib26","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ki.2012.230","article-title":"Regarding Maas\u2019s editorial letter on serum suPAR levels","volume":"82","author":"Trachtman","year":"2012","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.12045_bib27","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1681\/ASN.2005010055","article-title":"Podocyte depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene","volume":"16","author":"Wharram","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.12045_bib28","doi-asserted-by":"crossref","unstructured":"Matsusaka T, Sandgren E, Shintani A, et al. Podocyte injury damages other podocytes. J Am Soc Nephrol; 22: 1275\u20131285.","DOI":"10.1681\/ASN.2010090963"},{"key":"10.1111\/ajt.12045_bib29","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1681\/ASN.2007121328","article-title":"Urine podocyte mRNAs mark progression of renal disease","volume":"20","author":"Sato","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.12045_bib30","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1681\/ASN.2012030271","article-title":"Growth-dependent podocyte failure causes glomerulosclerosis","volume":"23","author":"Fukuda","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.12045_bib31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.mnh.0000165884.85803.e1","article-title":"Podocyte damage damages podocytes: Autonomous vicious cycle that drives local spread of glomerular sclerosis","volume":"14","author":"Ichikawa","year":"2005","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1111\/ajt.12045_bib32","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1681\/ASN.2011050486","article-title":"Podocyte injury can be catching","volume":"22","author":"D\u2019Agati","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.12045_bib33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000183469","article-title":"Plasmapheresis and dipyridamole for recurrent focal glomerular sclerosis","volume":"40","author":"Zimmerman","year":"1985","journal-title":"Nephron"},{"key":"10.1111\/ajt.12045_bib34","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1525-139X.2011.01031.x","article-title":"Therapeutic apheresis rescue mission: Recurrent focal segmental glomerulosclerosis in renal allografts","volume":"25","author":"Keith","year":"2012","journal-title":"Semin Dial"},{"key":"10.1111\/ajt.12045_bib35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1526-0968.2004.00164.x","article-title":"Effect of post-transplant double filtration plasmapheresis on recurrent focal and segmental glomerulosclerosis in renal transplant recipients","volume":"8","author":"Otsubo","year":"2004","journal-title":"Ther Apher Dial"},{"key":"10.1111\/ajt.12045_bib36","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1111\/j.1600-6143.2005.01112.x","article-title":"Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients","volume":"5","author":"Gohh","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12045_bib37","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1016\/j.transproceed.2007.09.045","article-title":"Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: Case reports","volume":"39","author":"Fencl","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.12045_bib38","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s004670100008","article-title":"Long-term plasmapheresis and protein A column treatment of recurrent FSGS","volume":"16","author":"Belson","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/ajt.12045_bib39","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nm.1857","article-title":"The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A","volume":"14","author":"Faul","year":"2008","journal-title":"Nat Med"},{"key":"10.1111\/ajt.12045_bib40","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/01.TP.0000055215.20367.21","article-title":"Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children","volume":"75","author":"Salomon","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12045_bib41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.ajkd.2004.03.028","article-title":"High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children","volume":"44","author":"Raafat","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/ajt.12045_bib42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00007890-199001000-00050","article-title":"High-dose cyclosporine therapy in recurrent nephrotic syndrome following renal transplantation","volume":"49","author":"Ingulli","year":"1990","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12045_bib43","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0272-6386(12)80493-8","article-title":"Recurrent and de novo renal disease after kidney transplantation with or without cyclosporine A","volume":"17","author":"Schwarz","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/ajt.12045_bib44","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1056\/NEJMc055495","article-title":"Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment","volume":"354","author":"Pescovitz","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.12045_bib45","doi-asserted-by":"crossref","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","article-title":"Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis","volume":"3","author":"Fornoni","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1111\/ajt.12045_bib46","doi-asserted-by":"crossref","first-page":"374213","DOI":"10.1155\/2011\/374213","article-title":"The factors that may predict response to rituximab therapy in recurrent focal segmental glomerulosclerosis: A systematic review","volume":"2011","author":"Araya","year":"2011","journal-title":"J Transplant"},{"key":"10.1111\/ajt.12045_bib47","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2215\/CJN.01180307","article-title":"Titrating rituximab to circulating B cells to optimize lymphocytolytic therapy in idiopathic membranous nephropathy","volume":"2","author":"Cravedi","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/ajt.12045_bib48","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1600-6143.2010.03029.x","article-title":"Low-dose rituximab for posttransplant recurrent membranous nephropathy","volume":"10","author":"Cravedi","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12045_bib49","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1525-1594.2010.01068.x","article-title":"Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation","volume":"35","author":"Tsagalis","year":"2011","journal-title":"Artif Organs"},{"key":"10.1111\/ajt.12045_bib50","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1432-2277.2009.00897.x","article-title":"Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation","volume":"22","author":"Freiberger","year":"2009","journal-title":"Transpl Int"},{"key":"10.1111\/ajt.12045_bib51","doi-asserted-by":"crossref","unstructured":"Cravedi P, Ruggenenti P, Remuzzi G. Sirolimus for calcineurin inhibitors in organ transplantation: Contra. Kidney Int; 78: 1068\u20131074.","DOI":"10.1038\/ki.2010.268"},{"key":"10.1111\/ajt.12045_bib52","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/00007890-199010000-00013","article-title":"The recurrence of focal segmental glomerulosclerosis in kidney transplant patients treated with cyclosporine","volume":"50","author":"Banfi","year":"1990","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12045_bib53","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00007890-199102000-00025","article-title":"Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children\u2013a single-center experience","volume":"51","author":"Ingulli","year":"1991","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12045_bib54","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1432-2277.2006.00395.x","article-title":"Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab","volume":"20","author":"Hristea","year":"2007","journal-title":"Transpl Int"},{"key":"10.1111\/ajt.12045_bib55","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1432-2277.2007.00477.x","article-title":"Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis","volume":"20","author":"Gossmann","year":"2007","journal-title":"Transpl Int"},{"key":"10.1111\/ajt.12045_bib56","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/j.1432-2277.2007.00562.x","article-title":"Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis","volume":"20","author":"Meyer","year":"2007","journal-title":"Transpl Int"},{"key":"10.1111\/ajt.12045_bib57","doi-asserted-by":"crossref","first-page":"250","DOI":"10.5414\/CNP67250","article-title":"Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports","volume":"67","author":"Kamar","year":"2007","journal-title":"Clin Nephrol"},{"key":"10.1111\/ajt.12045_bib58","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1600-6143.2007.02021.x","article-title":"Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis","volume":"8","author":"Yabu","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12045_bib59","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/ndt\/gfm616","article-title":"Post-transplant focal segmental glomerulosclerosis refractory to plasmapheresis and rituximab therapy","volume":"23","author":"El-Firjani","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ajt.12045_bib60","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/ndt\/gfn099","article-title":"Rituximab therapy in early recurrent focal segmental sclerosis after renal transplantation","volume":"23","author":"Apeland","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ajt.12045_bib61","doi-asserted-by":"crossref","first-page":"E121","DOI":"10.1111\/j.1399-3046.2010.01303.x","article-title":"Long-term effect of rituximab in maintaining remission of recurrent and plasmapheresis-dependent nephrotic syndrome post-renal transplantation\u2013case report","volume":"15","author":"Grenda","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1111\/ajt.12045_bib62","doi-asserted-by":"crossref","first-page":"389542","DOI":"10.1155\/2011\/389542","article-title":"Treatment of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: Effect of rituximab","volume":"2011","author":"Sethna","year":"2011","journal-title":"J Transplant"},{"key":"10.1111\/ajt.12045_bib63","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00467-009-1376-6","article-title":"Rituximab in refractory nephrotic syndrome","volume":"25","author":"Prytula","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/ajt.12045_bib64","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1016\/j.transproceed.2011.10.051","article-title":"Case report: Successful treatment of recurrent focal segmental glomerulosclerosis with a novel rituximab regimen","volume":"43","author":"Stewart","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.12045_bib65","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1007\/s00467-005-2013-7","article-title":"Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome","volume":"20","author":"Nozu","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/ajt.12045_bib66","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00467-007-0640-x","article-title":"Rituximab for refractory focal segmental glomerulosclerosis","volume":"23","author":"Nakayama","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/ajt.12045_bib67","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s00467-006-0260-x","article-title":"Does rituximab treat recurrent focal segmental glomerulosclerosis post-renal transplantation?","volume":"22","author":"Marks","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/ajt.12045_bib68","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1399-3046.2008.00967.x","article-title":"Rituximab for post-transplant recurrences of FSGS","volume":"13","author":"Bayrakci","year":"2009","journal-title":"Pediatr Transplant"},{"key":"10.1111\/ajt.12045_bib69","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1097\/TP.0b013e31819f12be","article-title":"Kidney transplantation for primary focal segmental glomerulosclerosis: Outcomes and response to therapy for recurrence","volume":"87","author":"Hickson","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12045_bib70","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.transproceed.2009.06.044","article-title":"Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis","volume":"41","author":"Rodriguez-Ferrero","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.12045_bib71","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/TP.0b013e3181aed9d7","article-title":"Use of rituximab in focal glomerulosclerosis relapses after renal transplantation","volume":"88","author":"Dello Strologo","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12045_bib72","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1600-6143.2009.02580.x","article-title":"Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: A pilot study","volume":"9","author":"Canaud","year":"2009","journal-title":"Am J Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.12045","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522257992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522257992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:59:31Z","timestamp":1761627571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522257992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1600613522257992"],"URL":"https:\/\/doi.org\/10.1111\/ajt.12045","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent Progress in the Pathophysiology and Treatment of FSGS Recurrence","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.12045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}